JLE

Epileptic Disorders

MENU

Evaluation of real-world effectiveness of perampanel in Japanese adults and older adults with epilepsy Volume 24, issue 1, February 2022

Figure 1

PER retention rate via Kaplan-Meier analysis in all patients and by age subgroup. PER: perampanel.

Figure 2

Responder rates (50%) in all patients and by age subgroup. FBTCS: focal to bilateral tonic-clonic seizure; FIAS: focal impaired awareness seizures; FAS: focal aware seizure; GTCS: generalised tonic-clonic seizure.

Figure 3

Efficacy rate in terms of overall symptom improvement in the efficacy analysis dataset. aOverall judgment of seizure frequency, seizure severity, adverse events, and overall daily living conditions. bTotal number of cases excluding “undecidable” cases.